Challenges in Colorectal Cancer / Edition 2by John Scholefield, Herand Abcarian, Tim Maughan, Axel Grothey
Pub. Date: 03/11/2008
Colorectal cancer is one of the most deadly forms of cancer in the US and Europe. In the US, every year nearly 150,000 people are diagnosed with the disease, and nearly 60,000 die. In the UK, 35,500 people are diagnosed with colorectal cancer each year and of these 16,000 die each year.Most of these deaths can be prevented using available screening tests and… See more details below
Colorectal cancer is one of the most deadly forms of cancer in the US and Europe. In the US, every year nearly 150,000 people are diagnosed with the disease, and nearly 60,000 die. In the UK, 35,500 people are diagnosed with colorectal cancer each year and of these 16,000 die each year.Most of these deaths can be prevented using available screening tests and treatments for the disease. This is because colorectal cancer is curable 90% of the time when detected early. In addition, screening tests can be used to detect certain pre-cancerous growths in the colon and rectum allowing them to be removed before they ever develop into cancer. Much has changed since the publication of the 1st edition of this book in 2001. The increased awareness (both within the medical profession and the general public) of colorectal cancer, together with the proposed screening programmes, will result in a higher rate of detection of the disease and therefore more patients. Although early detection is half the battle with this disease, at present 60% of patients will not be alive 5 years after diagnosis. The medical profession and the pharmaceutical industry have invested heavily in research to identify treatments to increase and prolong survival rates: we may soon see the dividends of this with the launch of a number of new pharmaceutical products. This book contains the latest data on the new and emerging treatments. This book provides the medical team caring for patients with colorectal cancer (gastroenterologists, surgeons, oncologists, gastroenterology specialty nurses, radiotherapists, etc) with the latest guidance on the most challenging and controversial aspects of this disease.
- Publication date:
- Edition description:
- Product dimensions:
- 6.40(w) x 9.45(h) x 0.85(d)
Table of Contents
List of contributors.
1 Richard Nelson.
Does lifestyle cause colorectal cancer?.
2 Robert Steele.
Screening for colorectal cancer – who, when, and how?.
3 Phil Quirke.
What can the pathologist tell the multidisciplinary team about rectal cancer resection?.
4 Brendan Morgan and John H. Scholefield.
MRI-directed rectal cancer surgery.
5 Pierre J. Guillou.
Minimally invasive surgery – where are we? Laparoscopic surgery for cancer of the colon and rectum.
6 Theodore J. Saclarides.
Minimally invasive surgery – where are we? Is there a role for TEM?.
7 Seung-Yong Jeong, David Chessin, Susan Ritchie, John H. Scholefield, and Jose G. Guillem.
What is the best strategy for the management of hereditary colorectal cancer?.
8 Rachel Cooper and David Sebag-Montefiore.
Adjuvant radiotherapy and chemoradiotherapy in the treatment of rectal cancer.
9 George P. Kim and Axel Grothey.
Current challenges in the adjuvant therapy of colon cancer.
10 Jill Dean.
The role of the colorectal nurse specialist in the management of colorectal cancer.
11 Julia Jessop and Ian Daniels.
The role of the multidisciplinary team in the management of colorectal cancer.
12 John Northover and Chris Byrne.
Follow-up after colorectal cancer resection: Is it worthwhile?.
13 Axel Grothey.
Chemotherapy of advanced colorectal cancer.
14 Timothy G. John and Myrddin Rees.
Surgery for metastatic disease in colorectal cancer.
15 Melanie Jefferson and Ilora Finlay.
Palliative care of the colorectal cancer patient.
16 Anthony E l–Khoueiry and Heinz-Josef Lenz.
Future directions in the oncological treatment of colorectal cancer.
and post it to your social network
Most Helpful Customer Reviews
See all customer reviews >